³í¹®½ÇÀû

Áö¿ø°úÁ¦º° :
¿¬µµº° :
¸ðµÎº¸±â
Integration of Genetic, Clinical, and INR Data to Refine Warfarin Dosing(PRCDM)
Clin Pharmacol Ther. 87(5):572-8 / 2010.05 [LINK]
2010-International
A haplotype of CYP2C9 associated with warfarin sensitivity in mechanical heart valve replacement patients(BMRC, PRCDM)
Br J Clin Pharmacol. 70(2):213-21. / 2010.08 [LINK]
2010-International
Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across three racial groups.(BMRC, PRCDM)
Blood 115(18):3827-34 / 2010.05 [LINK]
2010-International
Effects of woohwangcheongsimwon suspension on the pharmacokinetics of bupropion and its active metabolite, 4-hydroxybupropion, in healthy subjects.(BMRC, PRCDM)
Br J Clin Pharmacol. 70(1):126-31 / 2010.07 [LINK]
Establishment and characterization of Mardin-Darby canine kidney cells stably expressing human organic anion transporters.(PRCDM, ¿¬±¸±³¼ö)
Arch Pharm Res. 33(5):709-16 / 2010.05 [LINK]
Identification of CYP19A1 single nucleotide polymorphisms and their haplotype distributions in a Korean population(BMRC, PRCDM)
J Hum Genet. 55(3):189-93 / 2010.03 [LINK]
Significantly the Disposition and Antihistamine Effect of Ebastine and Its Metabolites in Healthy Participants(BMRC, PRCDM)
J Clin Pharmacol. 50(2):195-204 [LINK]
2010-International
Murrayafoline A attenuates the Wnt/beta-catenin pathway by promoting the degradation of intracellular beta-catenin proteins.()
Biochem Biophys Res Commun. 391(1):915-20 [LINK]
2010-International
Identification of a null allele of cytochrome P450 3A7: CYP3A7 polymorphism in a Korean population(BMRC)
Mol Biol Rep. 37(1):213-7 [LINK]
2010-International
Identification of genetic polymorphisms of human OAT1 and OAT2 genes and their relationship to hOAT2 expression in human liver(BMRC, ¼ö¼Ûü)
Clinica Chimica Acta 411(1-2):99-105 [LINK]
2010-International